Literature DB >> 26082912

Interleukin-1β in Central Nervous System Injury and Repair.

Nicole A Jackman1, Robert J Claycomb2, Sandra J Hewett3.   

Abstract

Acute inflammation is a self-limiting, complex biological response mounted to combat pathogen invasion, to protect against tissue damage, and to promote tissue repair should it occur. However, unabated inflammation can be deleterious and contribute to injury and pathology. Interleukin-1β (IL-1β), a prototypical "pro-inflammatory" cytokine, is essential to cellular defense and tissue repair in nearly all tissues. With respect to brain, however, studies suggest that IL-1β has pleiotrophic effects. It acts as a neuromodulator in the healthy central nervous system (CNS), has been implicated in the pathogenic processes associated with a number of CNS maladies, but may also provide protection to the injured CNS. Here, we will review the physiological and pathophysiological functions of IL-1β in the central nervous system with regard to synaptic plasticity. With respect to disease, emphasis will be placed on stroke, epilepsy, Parkinson's disease and Alzheimer's disease where the ultimate injurious or reparative effects of IL-1β appear to depend on time, concentration and environmental milieu.

Entities:  

Keywords:  IL-1; Injury; Interleukin 1; Neurodegeneration; Neuroinflammation; Neurological disease; Protection; Repair

Year:  2012        PMID: 26082912      PMCID: PMC4465544     

Source DB:  PubMed          Journal:  Eur J Neurodegener Dis        ISSN: 2279-5855


  207 in total

1.  Comparison of two forms of long-term potentiation in single hippocampal neurons.

Authors:  R A Zalutsky; R A Nicoll
Journal:  Science       Date:  1990-06-29       Impact factor: 47.728

2.  Intrathecal expression of proteins regulating apoptosis in acute stroke.

Authors:  E Tarkowski; L Rosengren; C Blomstrand; C Jensen; S Ekholm; A Tarkowski
Journal:  Stroke       Date:  1999-02       Impact factor: 7.914

Review 3.  Role of membrane transport in metabolism and function of glutathione in mammals.

Authors:  S Bannai; N Tateishi
Journal:  J Membr Biol       Date:  1986       Impact factor: 1.843

4.  Interleukin-1beta mediates GDNF up-regulation upon dopaminergic injury in ventral midbrain cell cultures.

Authors:  Ana Saavedra; Graça Baltazar; Emília P Duarte
Journal:  Neurobiol Dis       Date:  2006-10-05       Impact factor: 5.996

5.  Mice deficient in interleukin-1 converting enzyme are resistant to neonatal hypoxic-ischemic brain damage.

Authors:  X H Liu; D Kwon; G P Schielke; G Y Yang; F S Silverstein; J D Barks
Journal:  J Cereb Blood Flow Metab       Date:  1999-10       Impact factor: 6.200

6.  Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients.

Authors:  D Blum-Degen; T Müller; W Kuhn; M Gerlach; H Przuntek; P Riederer
Journal:  Neurosci Lett       Date:  1995-12-29       Impact factor: 3.046

7.  The interleukin-1 type I receptor is expressed in human hypothalamus.

Authors:  E A Hammond; D Smart; S Toulmond; N Suman-Chauhan; J Hughes; M D Hall
Journal:  Brain       Date:  1999-09       Impact factor: 13.501

8.  Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures.

Authors:  A Vezzani; M Conti; A De Luigi; T Ravizza; D Moneta; F Marchesi; M G De Simoni
Journal:  J Neurosci       Date:  1999-06-15       Impact factor: 6.167

9.  Interleukin-1 mediates Alzheimer and Lewy body pathologies.

Authors:  W Sue T Griffin; Ling Liu; Yuekui Li; Robert E Mrak; Steven W Barger
Journal:  J Neuroinflammation       Date:  2006-03-16       Impact factor: 8.322

10.  Role of cytokines during epileptogenesis and in the transition from the interictal to the ictal state in the epileptic mutant EL mouse.

Authors:  Yoshiya L Murashima; Jiro Suzuki; Mitsunobu Yoshii
Journal:  Gene Regul Syst Bio       Date:  2008-08-27
View more
  50 in total

1.  Maternal immune markers during pregnancy and child neurodevelopmental outcomes at age 20 months in the Seychelles Child Development Study.

Authors:  Jessica L Irwin; Emeir M McSorley; Alison J Yeates; Maria S Mulhern; J J Strain; Gene E Watson; Katherine Grzesik; Sally W Thurston; Tanzy M Love; Tristram H Smith; Karin Broberg; Conrad F Shamlaye; Gary J Myers; Philip W Davidson; Edwin van Wijngaarden
Journal:  J Neuroimmunol       Date:  2019-08-14       Impact factor: 3.478

2.  Interleukin-1β protects astrocytes against oxidant-induced injury via an NF-κB-dependent upregulation of glutathione synthesis.

Authors:  Yan He; Nicole A Jackman; Trista L Thorn; Valarie E Vought; Sandra J Hewett
Journal:  Glia       Date:  2015-04-16       Impact factor: 7.452

3.  Evaluating the Role of IL-1β in Transmigration of Triple Negative Breast Cancer Cells Across the Brain Endothelium.

Authors:  Pedram Motallebnejad; Vinayak V Rajesh; Samira M Azarin
Journal:  Cell Mol Bioeng       Date:  2021-10-26       Impact factor: 2.321

4.  Systems Genetics and Systems Biology Analysis of Paraquat Neurotoxicity in BXD Recombinant Inbred Mice.

Authors:  Carolina Torres-Rojas; Daming Zhuang; Paola Jimenez-Carrion; Isabel Silva; James P O'Callaghan; Lu Lu; Wenyuan Zhao; Megan K Mulligan; Robert W Williams; Byron C Jones
Journal:  Toxicol Sci       Date:  2020-07-01       Impact factor: 4.849

5.  Atorvastatin Modulates Regulatory T Cells and Attenuates Cerebral Damage in a Model of Transient Middle Cerebral Artery Occlusion in Rats.

Authors:  Ana Lucía Rodríguez-Perea; Johanna Gutierrez-Vargas; Gloria Patricia Cardona-Gómez; Carlos Julio Montoya Guarin; Mauricio Rojas; Paula Andrea Velilla Hernández
Journal:  J Neuroimmune Pharmacol       Date:  2016-09-10       Impact factor: 4.147

6.  Interleukin 1β Regulation of the System xc- Substrate-specific Subunit, xCT, in Primary Mouse Astrocytes Involves the RNA-binding Protein HuR.

Authors:  Jingxue Shi; Yan He; Sandra J Hewett; James A Hewett
Journal:  J Biol Chem       Date:  2015-11-24       Impact factor: 5.157

7.  IL-6 Inhibition Reduces Neuronal Injury in a Murine Model of Ventilator-induced Lung Injury.

Authors:  Nicklaus A Sparrow; Faizan Anwar; Ambart E Covarrubias; Padmesh S Rajput; Mohammad Harun Rashid; Peyton L Nisson; Michael M Gezalian; Shahed Toossi; Maranatha O Ayodele; S Ananth Karumanchi; E Wesley Ely; Shouri Lahiri
Journal:  Am J Respir Cell Mol Biol       Date:  2021-10       Impact factor: 6.914

8.  The Cannabinoid Receptor Agonist, WIN-55212-2, Suppresses the Activation of Proinflammatory Genes Induced by Interleukin 1 Beta in Human Astrocytes.

Authors:  Jerel Adam Fields; Mary K Swinton; Patricia Montilla-Perez; Eugenia Ricciardelli; Francesca Telese
Journal:  Cannabis Cannabinoid Res       Date:  2020-12-31

9.  Capturing T Lymphocytes' Dynamic Interactions With Human Neural Cells Using Time-Lapse Microscopy.

Authors:  Florent Lemaître; Ana Carmena Moratalla; Negar Farzam-Kia; Yves Carpentier Solorio; Olivier Tastet; Aurélie Cleret-Buhot; Jean Victor Guimond; Elie Haddad; Nathalie Arbour
Journal:  Front Immunol       Date:  2021-04-22       Impact factor: 7.561

10.  Modulating Expression of Endogenous Interleukin 1 Beta in the Acute Phase of the Pilocarpine Model of Epilepsy May Change Animal Survival.

Authors:  R B Marchesini; V D B Pascoal; M C P Athié; A H B Matos; F F Conte; T C Pereira; R Secolin; R Gilioli; J M Malheiros; R S Polli; A Tannús; L Covolan; L B Pascoal; A S Vieira; E A Cavalheiro; F Cendes; I Lopes-Cendes
Journal:  Cell Mol Neurobiol       Date:  2022-01-21       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.